Injection, pegfilgrastim-apgf (nyvepria), biosimilar, 0.5 mg
Miscellaneous Services (Temporary Codes)
Q5122 is a valid 2026 HCPCS code for Injection, pegfilgrastim-apgf (nyvepria), biosimilar, 0.5 mg or just “Inj, nyvepria” for short, used in Medical care.
| HCPCS Level II Code Miscellaneous Services (Temporary Codes) |
|
| HCPCS Code | Q5122 |
|---|---|
| Description |
Long description:
Short description: |
| HCPCS Modifier1 | |
| HCPCS Pricing indicator |
51 - Drugs
|
| Multiple pricing indicator |
A - Not applicable as HCPCS priced under one methodology
|
| Coverage code | C - Carrier judgment |
| ASC payment group code | Effective Jan 01, 2021 - This procedure is approved to be performed in an ambulatory surgical center. |
| BETOS2 code | O1E - Other drugs |
| HCPCS Action code | N - No maintenance for this code |
| Type of service | 1 - Medical care |
| Effective date | Effective Apr 01, 2023 |
| Date added | Added Jan 01, 2021 |
| HCPCS Coding Procedures | |
In HCPCS Level II, modifiers are composed of two alpha or alphanumeric characters.
Example: E0260-NU - Hospital bed, semi-electric (head and foot adjustment), with any type side rails, with mattress
“NU” identifies the hospital bed as new equipment
| Effective | Code Dosage | Payment Limit |
Vaccine AWP % | Vaccine Limit | Infusion AWP % | DME infusion limit | Blood AWP % | Blood limit | Clotting factor | Note |
|---|---|---|---|---|---|---|---|---|---|---|
| April 1, 2026 - June 30, 2026 | 0.5 MG | 133.311 | - | - | - | - | - | - | ||
| January 1, 2026 - March 31, 2026 | 0.5 MG | 133.054 | - | - | - | - | - | - | ||
| October 1, 2025 - December 31, 2025 | 0.5 MG | 131.158 | - | - | - | - | - | - | ||
| Jul 1, 2025 - Sep 30, 2025 | 0.5 MG | 132.039 | - | - | - | - | - | - | ||
| April 1, 2025 - June 30, 2025 | 0.5 MG | 134.252 | - | - | - | - | - | - |
1 Two-digit numeric codes are Level I code modifiers copyrighted© by the American Medical Association's Current Procedural Terminology (CPT).
2 BETOS stands for “Berenson-Eggers Type Of Service”